Laserfiche WebLink
APPENDIX <br />Repealed Minnesota Statutes: HO100-9 <br />clinical outcomes, and quality -of -life outcomes for the purpose of reporting on the benefits, risks, <br />and outcomes regarding patients with a qualifying medical condition engaged in the therapeutic <br />use of medical cannabis. <br />(b) The establishment of the registry program shall not be construed or interpreted to condone <br />or promote the illicit recreational use of marijuana. <br />Subd. 2. Commissioner duties. (a) The commissioner shall: <br />(1) give notice of the program to health care practitioners in the state who are eligible to serve <br />as health care practitioners and explain the purposes and requirements of the program; <br />(2) allow each health care practitioner who meets or agrees to meet the program's requirements <br />and who requests to participate, to be included in the registry program to collect data for the patient <br />registry; <br />(3) provide explanatory information and assistance to each health care practitioner in <br />understanding the nature of therapeutic use of medical cannabis within program requirements; <br />(4) create and provide a certification to be used by a health care practitioner for the practitioner <br />to certify whether a patient has been diagnosed with a qualifying medical condition and include in <br />the certification an option for the practitioner to certify whether the patient, in the health care <br />practitioner's medical opinion, is developmentally or physically disabled and, as a result of that <br />disability, the patient requires assistance in administering medical cannabis or obtaining medical <br />cannabis from a distribution facility; <br />(5) supervise the participation of the health care practitioner in conducting patient treatment <br />and health records reporting in a manner that ensures stringent security and record -keeping <br />requirements and that prevents the unauthorized release of private data on individuals as defined <br />by section 13.02; <br />(6) develop safety criteria for patients with a qualifying medical condition as a requirement of <br />the patient's participation in the program, to prevent the patient from undertaking any task under <br />the influence of medical cannabis that would constitute negligence or professional malpractice on <br />the part of the patient; and <br />(7) conduct research and studies based on data from health records submitted to the registry <br />program and submit reports on intermediate or final research results to the legislature and major <br />scientific journals. The commissioner may contract with a third party to complete the requirements <br />of this clause. Any reports submitted must comply with section 152.28, subdivision 2. <br />(b) The commissioner may add a delivery method under section 152.22, subdivision 6, or add, <br />remove, or modify a qualifying medical condition under section 152.22, subdivision 14, upon a <br />petition from a member of the public or the task force on medical cannabis therapeutic research or <br />as directed by law. The commissioner shall evaluate all petitions to add a qualifying medical <br />condition or to remove or modify an existing qualifying medical condition submitted by the task <br />force on medical cannabis therapeutic research or as directed by law and may make the addition, <br />removal, or modification if the commissioner determines the addition, removal, or modification is <br />warranted based on the best available evidence and research. If the commissioner wishes to add a <br />delivery method under section 152.22, subdivision 6, or add or remove a qualifying medical condition <br />under section 152.22, subdivision 14, the commissioner must notify the chairs and ranking minority <br />members of the legislative policy committees having jurisdiction over health and public safety of <br />the addition or removal and the reasons for its addition or removal, including any written comments <br />received by the commissioner from the public and any guidance received from the task force on <br />medical cannabis research, by January 15 of the year in which the commissioner wishes to make <br />the change. The change shall be effective on August 1 of that year, unless the legislature by law <br />provides otherwise. <br />Subd. 3. Patient application. (a) The commissioner shall develop a patient application for <br />enrollment into the registry program. The application shall be available to the patient and given to <br />health care practitioners in the state who are eligible to serve as health care practitioners. The <br />application must include: <br />(1) the name, mailing address, and date of birth of the patient; <br />(2) the name, mailing address, and telephone number of the patient's health care practitioner; <br />10R <br />